Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Anti-Reflux Infant Formula Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The anti-reflux infant formula market size has experienced significant expansion in recent years. Projections indicate it will grow from $74.24 billion in 2025 to $81.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. This past growth can be ascribed to a rising incidence of infant gastroesophageal reflux cases, increasing public awareness concerning infant digestive disorders, greater adoption of infant nutrition products, more frequent recommendations from pediatric healthcare professionals, and a surging demand for specialty infant formulas.
The anti-reflux infant formula market size is anticipated to experience robust growth over the next few years, projected to reach $117.14 billion by 2030 with a compound annual growth rate (CAGR) of 9.5%. This expansion during the forecast period can be attributed to the increasing development of clinically advanced infant formulas, a rising demand for customized nutritional solutions, a growing focus on infant gut health management, the proliferation of premium pediatric nutrition products, and increased investment in specialized infant healthcare products. Key trends expected in this period include a heightened demand for clinically formulated anti-reflux nutrition products, a rising preference for hydrolyzed and easily digestible ingredients, the increasing use of specialty formulas for managing infant digestive health, a greater adoption of medically supervised infant nutrition solutions, and the expansion of allergy-specific and reflux-focused infant formulations.
Get A Free Sample Report With In-Depth Market Insights:
Anti-Reflux Infant Formula Market Growth Drivers: What’s Behind The Acceleration?
The overall rise in the infant population is anticipated to fuel the expansion of the anti-reflux infant formula market in the coming years. An infant refers to a child from birth up to approximately one year old, relying entirely on caregivers for fundamental needs and early development. The growth in infant numbers is attributed to increasing birth rates, supported by advancements in healthcare and enhanced living standards. Anti-reflux infant formula aids infants by facilitating the retention of feeds, thereby helping to minimize regurgitation and foster improved nutrient absorption. For example, in July 2025, the Office for National Statistics Census, a UK government agency, reported that England and Wales recorded 594,677 live births in 2024, representing an increase of 3,605 births (0.6%) compared to 591,072 live births in 2023. Consequently, the growing total number of infants is a key factor driving the anti-reflux infant formula market forward. The increasing involvement of mothers in the workforce is projected to boost the growth of the anti-reflux infant formula market moving forward. Working mothers are women who have children and and are engaged in paid employment, navigating the dual responsibilities of childcare and professional life outside the home. The rise in working mothers is primarily due to escalating living costs, which necessitate dual incomes to cover household expenses. Anti-reflux infant formula assists working mothers by diminishing infant spit-up and feeding discomfort, thereby making feeding routines more predictable and simpler to manage amidst demanding work schedules. For instance, in April 2024, the Bureau of Labor Statistics, a US-based government agency, reported that the percentage of working mothers with children under 18 reached 74% in 2023, marking an increase of 1.1 percentage points from the previous year. Hence, the growing population of working mothers is a significant force behind the expansion of the anti-reflux infant formula market.
Anti-Reflux Infant Formula Market Segment Breakdown: Which Categories Lead On Revenue?
The anti-reflux infant formula market covered in this report is segmented –
1) By Product Type: Thickened Formula, Pre Thickened Formula, Specialty Formula
2) By Ingredient: Cow Milk Based, Soy Based, Protein Hydrolysate Based, Other Ingredients
3) By Age Group: Zero To Six Months, Six To Twelve Months, Twelve To Twenty Four Months
4) By Distribution Channel: Supermarkets Or Hypermarkets, Pharmacies Or Drug Stores, Online Stores, Specialty Stores, Other Distribution Channels
5) By End User: Hospitals And Neonatal Intensive Care Units, Homecare Settings, Pediatric Clinics
Subsegments:
1) By Thickened Formula: Rice Starch Based Thickened Formula, Corn Starch Based Thickened Formula, Potato Starch Based Thickened Formula, Carob Bean Gum Thickened Formula, Rice Cereal Added Thickened Formula
2) By Pre Thickened Formula: Ready To Feed Pre Thickened Liquid Formula, Powdered Pre Thickened Formula, Liquid Concentrate Pre Thickened Formula, Anti Regurgitation Ready To Feed Specialty Liquids, Pre Thickened Follow On Formula
3) By Specialty Formula: Extensively Hydrolyzed Protein Anti Reflux Formula, Amino Acid Based Anti Reflux Formula, Lactose Free Anti Reflux Formula, Organic Specialty Anti Reflux Formula, Preterm Or Low Birth Weight Anti Reflux Formula, Allergy Specific Formula
Anti-Reflux Infant Formula Market Leading Players And Competitive Positioning
Major companies operating in the anti-reflux infant formula market report are Humana GmbH, Nestlé SA, Abbott Laboratories, Danone SA, Reckitt Benckiser Group plc, Royal FrieslandCampina NV, Perrigo Company plc, The Hain Celestial Group Inc, Hero Group AG, HiPP GmbH & Co Vertrieb KG, Richen Nutritional Technology Co Ltd, Kendal Nutricare Ltd, Laboratorios Ordesa SL, Geo-Poland Sp z oo, Fasska Sp z oo, Lactalis Nutrition Santé SAS, Medical Brands Innovations BV, Laboratorios Basi, Sanulac Nutritionals BV, Bellamy’s Organic, Bubs Australia, Nannycare
View The Full Anti-Reflux Infant Formula Market Report:
Anti-Reflux Infant Formula Market Top Region By Revenue And Market Share
North America was the largest region in the anti-reflux infant formula market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-reflux infant formula market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.